Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74e9088672e12e0c3d46f1e5054dc9e3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
filingDate |
2013-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69642641a32dc07b52a7cd68da155faa |
publicationDate |
2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2013164204-A1 |
titleOfInvention |
Tritoqualine for use in the treatment of cystic fibrosis |
abstract |
This invention relates to tritoqualine for use in the treatment of cystic fibrosis or any one of its complications. The invention also relates to the method for the treatment of cystic fibrosis or any one of its complications by administering tritoqualine. The invention can be used to improve the condition of individuals with cystic fibrosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015101727-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3015977-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9670163-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701639-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2854947-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2854947-B1 |
priorityDate |
2012-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |